Anthony Lucci, MD

Articles by Anthony Lucci, MD

69 The Importance of Tri-Modality Therapy for De Novo Stage IV Invasive Lobular Carcinoma (ILC) Presenting With Bone-Only Metastases

ByAttilla Soran,Berk Goktepe,Berkay Demirors,Serdar Ozbas,Efe Sezgin,Jamila Al-Azhri,Shruti Zaveri,S. Meas,Anthony Lucci, MD,Priscilla F. Mcauliffe, MD, PhD

April 21st 2024

How Heterogeneous Cell Populations, Cancer Cell Dormancy, and Minimal Residual Disease Influence the Natural History of Cancers

ByCarolyn Hall, PhD,Anthony Lucci, MD

January 15th 2011

The authors of “How Long Have I Had My Cancer, Doctor?” have addressed a question often contemplated by patients when they receive a diagnosis of cancer.

Latest Updated Articles

How Heterogeneous Cell Populations, Cancer Cell Dormancy, and Minimal Residual Disease Influence the Natural History of Cancers
January 15th 2011

Anthony Lucci, MD

Articles by Anthony Lucci, MD

69 The Importance of Tri-Modality Therapy for De Novo Stage IV Invasive Lobular Carcinoma (ILC) Presenting With Bone-Only Metastases

How Heterogeneous Cell Populations, Cancer Cell Dormancy, and Minimal Residual Disease Influence the Natural History of Cancers

Latest Updated Articles

Trending on CancerNetwork

Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma

Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs

COA Warns That Price Negotiation for Medicare Part B Drugs Threatens Community Oncology

Using Intrathecal Dendritic Cells for Leptomeningeal Disease From Breast Cancer